More than 3 Million Doses of Gadopiclenol Delivered by Bracco

Bracco’s gadopiclenol delivers effective contrast enhancement at half the gadolinium dose (0.05 mmol/kg) compared to other macrocyclic GBCAs - helping reduce cumulative Gd exposure without compromising diagnostic confidence. Three million doses administered worldwide mark an important milestone that confirms the trust of the medical community in a solution that combines safety , efficacy , and sustainability . For more than 95 years, Bracco Group has been advancing standards of care in radiology. Our commitment extends far beyond delivering trusted contrast agents and is reflected in: A broad portfolio and range of customer services that make us the radiology partner of choice Integrated clinical support and continuing education A focus on environmental sustainability and more conscientious use of gadolinium Strategic partnerships and continuous innovation since 1927, now supporting patients and radiology professionals in more than 100 countries GL-VW-2500051

The release as fetched from its publisher. bracco.com ↗